Brain concentrations of d-MDMA are increased after stress (Q23912492)

Dimensions

5 April 2023

2

James P. O’Callaghan

James P.

O’Callaghan

1 reference

Dimensions

1012834598

5 April 2023

author name string

Elizabeth Anne Johnson

series ordinal

1

author given names

Elizabeth Anne

author last names

Johnson

1 reference

Dimensions

1012834598

5 April 2023

language of work or name

English

1 reference

on focus list of Wikimedia project

inferred from title

process of elimination

publication date

20 January 2004

0 references

published in

Psychopharmacology

0 references

volume

173

0 references

issue

3-4

0 references

page(s)

278-286

0 references

Wikimedia–NIOSH collaboration

0 references

cites work

Development and characterization of a binge drinking model in mice for evaluation of the immunological effects of ethanol

1 reference

12 December 2020

Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase

1 reference

12 December 2020

Restraint as a stressor in mice: against the dopaminergic neurotoxicity of D-MDMA - low body weight mitigates restraint-induced hypothermia and consequent neuroprotection

1 reference

12 December 2020

Enhancement of 3,4-methylenedioxymethamphetamine neurotoxicity by the energy inhibitor malonate

1 reference

12 December 2020

Lack of serotonin neurotoxicity after intraraphe microinjection of ( )-3,4-methylenedioxymethamphetamine (MDMA)

1 reference

12 December 2020

3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose

1 reference

12 December 2020

Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs ('Ecstasy')

1 reference

12 December 2020

Stereochemical differences in the metabolism of 3,4-methylenedioxymethamphetamine in vivo and in vitro: a pharmacokinetic analysis

1 reference

12 December 2020

Measurement of protein using bicinchoninic acid

1 reference

12 December 2020

Amphetamine levels in brain microdialysate, caudate/putamen, substantia nigra and plasma after dosage that produces either behavioral or neurotoxic effects

1 reference

12 December 2020

Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat.

1 reference

12 December 2020

Ethanol-induced activation of the hypothalamic-pituitary-adrenal axis in a mouse model for binge drinking: role of Ro15-4513-sensitive gamma aminobutyric acid receptors, tolerance, and relevance to humans

1 reference

12 December 2020

Identification of the human cytochromes P450 involved in the oxidative metabolism of "Ecstasy"-related designer drugs

1 reference

12 December 2020

Interactions of amphetamine analogs with human liver CYP2D6

1 reference

12 December 2020

Genomic characterization and regulation of CYP3a13: role of xenobiotics and nuclear receptors

1 reference

12 December 2020

Regulation of hepatic cytochrome P450 2C11 by glucocorticoids

1 reference

12 December 2020

Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse

1 reference

12 December 2020

Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability

1 reference

12 December 2020

Identification of drugs inhibiting the in vitro metabolism of tacrolimus by human liver microsomes

1 reference

12 December 2020

Studies, using in vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 on 3,4-methylenedioxymethamphetamine ('ecstasy')-induced dopamine release and free radical formation in the mouse striatum

1 reference

12 December 2020

A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurones in mouse brain

1 reference

12 December 2020

Chronic treatment with supraphysiological levels of corticosterone enhances d-MDMA-induced dopaminergic neurotoxicity in the C57BL/6J female mouse

1 reference

12 December 2020

Oxidation of methamphetamine and methylenedioxymethamphetamine by CYP2D6

1 reference

12 December 2020

Characterization of Cyp2d22, a novel cytochrome P450 expressed in mouse mammary cells

1 reference

12 December 2020

Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism

1 reference

12 December 2020

Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse

1 reference

12 December 2020

The demethylenation of methylenedioxymethamphetamine ("ecstasy") by debrisoquine hydroxylase (CYP2D6)

1 reference

12 December 2020

The role of temperature, stress, and other factors in the neurotoxicity of the substituted amphetamines 3,4-methylenedioxymethamphetamine and fenfluramine

1 reference

12 December 2020

Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain

1 reference

12 December 2020

Persistent loss of thermoregulation in the rat induced by 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy") but not by fenfluramine.

1 reference

12 December 2020

Measurement of glial fibrillary acidic protein

1 reference

Crossref

https://api.crossref.org/works/10.1007/S00213-003-1740-3

7 January 2021

inferred from DOI database lookup

Neurotoxic effects of substituted amphetamines in rats and mice

1 reference

Crossref

https://api.crossref.org/works/10.1007/S00213-003-1740-3

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1007/S00213-003-1740-3

0 references